BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 15, 2005
View Archived Issues
FDA Seen As More Stringent Regarding Drug Safety Issues
Read More
Xsira Licenses Clinical-Stage Adenosine-Based Compound
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
Stressgen Sells Bioreagents Unit To Better Focus On Lead Product
Concentrating its efforts on its lead drug, HspE7, Stressgen Biotechnologies Corp. agreed to divest its bioreagents business in a move that adds a bit of capital to its coffers. (BioWorld Today)
Read More
Deal Transforming Bionaut From Platform To Products
Read More